Retraction-validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial (Retraction of vol 8, pg 1071, 2007)

被引：16

作者：

Bonnefoi, Herve ^{[1
]}

Potti, Anil ^{[1
]}

Delorenzi, Mauro ^{[1
]}

Mauriac, Louis ^{[1
]}

Campone, Mario ^{[1
]}

Tubiana-Hulin, Michele ^{[1
]}

Petit, Thierry ^{[1
]}

Rouanet, Philippe ^{[1
]}

Jassem, Jacek ^{[1
]}

Blot, Emmanuel ^{[1
]}

Becette, Veronique ^{[1
]}

Farmer, Pierre ^{[1
]}

Andre, Sylvie ^{[1
]}

Acharya, Chaitanya R. ^{[1
]}

Mukherjee, Sayan ^{[1
]}

Cameron, David ^{[1
]}

Bergh, Jonas ^{[1
]}

Nevins, Joseph R. ^{[1
]}

Iggo, Richard D. ^{[1
]}

机构：

[1] Univ Bordeaux, Bergonie Canc Inst, Bordeaux, France

来源：

LANCET ONCOLOGY | 2011年 / 12卷 / 02期

关键词：

D O I：

10.1016/S1470-2045(11)70011-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：116 / 116

页数：1

共 4 条

[1]

RETRACTED: Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial (Retracted Article. See vol 12, pg 116, 2011) [J].

不详 .

LANCET ONCOLOGY, 2007, 8 (12) :1071-1078

[2]

Expression of concern validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial [J].

Collingridge, David .

LANCET ONCOLOGY, 2010, 11 (09) :813-814

[3]

RETRACTED: Genomic signatures to guide the use of chemotherapeutics (Retracted article. See vol. 17, pg. 135, 2011) [J].

Potti, Anil ;

Dressman, Holly K. ;

Bild, Andrea ;

Riedel, Richard F. ;

Chan, Gina ;

Sayer, Robyn ;

Cragun, Janiel ;

Cottrill, Hope ;

Kelley, Michael J. ;

Petersen, Rebecca ;

Harpole, David ;

Marks, Jeffrey ;

Berchuck, Andrew ;

Ginsburg, Geoffrey S. ;

Febbo, Phillip ;

Lancaster, Johnathan ;

Nevins, Joseph R. .

NATURE MEDICINE, 2006, 12 (11) :1294-1300

[4]

Potti A, 2011, NAT MED, V17, P135, DOI 10.1038/nm0111-135

← 1 →